Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

Trial Profile

Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2017

At a glance

  • Drugs Defibrotide (Primary)
  • Indications Hepatic veno-occlusive disease
  • Focus Expanded access; Registrational; Therapeutic Use
  • Acronyms T-IND
  • Sponsors Jazz Pharmaceuticals Inc
  • Most Recent Events

    • 12 Dec 2017 Final results of adult subgroup outcomes data (n=1000) presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
    • 12 Dec 2017 Results of post-hoc analysis (n=1000) presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
    • 12 Dec 2017 Results (n=1154) of post hoc analysis of final data, were presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top